| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 02/28/2001 | EP1077945A1 Isoquinolines as urokinase inhibitors |
| 02/28/2001 | EP1077942A1 Carboxy substituted carboxamide derivatives as tachykinin receptor antagonists |
| 02/28/2001 | EP1077701A1 Anti-viral compounds |
| 02/28/2001 | EP1077691A1 Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same |
| 02/28/2001 | CN1285514A Medicine box bof testing anti-hepatitis C virus antibody |
| 02/27/2001 | US6194408 Parasiticides |
| 02/27/2001 | US6194392 Administering to a patient suffering from swelling associated with brain tumours involving tissue of the group consisting of underperfused tissue and pathological tissue an antiswelling agent and a hyaluronic acid to aid penetration |
| 02/27/2001 | CA2317064A1 Pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal |
| 02/27/2001 | CA2316647A1 Treatment or prevention of coccidiosis |
| 02/27/2001 | CA1341189C Use of 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid or its salts for the protection of hair against atmospheric agressions, and particularly against light, and process for hairprotection with this compound |
| 02/22/2001 | WO2001012627A1 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 02/22/2001 | WO2001012611A1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 02/22/2001 | WO2001012229A1 Pharmaceutical compositions for oral and topical administration |
| 02/22/2001 | WO2001012208A1 Use of ginkgo extract |
| 02/22/2001 | WO2001012181A1 Improved topical medicaments and methods for photodynamic treatment of disease |
| 02/22/2001 | WO2000071538A3 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
| 02/22/2001 | WO2000061122A3 Use of 6-methylmercaptopurine riboside in ophthalmologic compositions |
| 02/22/2001 | WO2000023065A8 Storable active substance concentrate with formoterol |
| 02/22/2001 | CA2452118A1 Pharmaceutical compositions for oral and topical administration |
| 02/22/2001 | CA2381975A1 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 02/22/2001 | CA2381551A1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 02/22/2001 | CA2380936A1 Therapeutic antibody against muc-1 antigen and methods for their use |
| 02/21/2001 | EP1076703A2 Il-17 homologous polypeptides and therapeutic uses thereof |
| 02/21/2001 | CN1284942A Matrix metalloprotease inhibitors |
| 02/21/2001 | CN1284855A Antiperspirant cream compositions having improved wash-off and antiperspirant efficacy |
| 02/21/2001 | CN1062151C Medicinal compsn. for treatment of heperosteogeny and its prepn. |
| 02/20/2001 | US6191140 Potassium channel modulators; muscle relaxants; controlling cell membranes |
| 02/20/2001 | US6190675 Mild, rinse-off antimicrobial liquid cleansing compositions which provide improved residual benefit versus gram positive bacteria |
| 02/20/2001 | US6190674 Mild, rinse-off, personal cleansing formulation; for treating acne; effective against gramnegative bacteria |
| 02/20/2001 | CA2223624C Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-.alpha.]pyridines |
| 02/20/2001 | CA2076749C Vasoactive vasotocin derivatives |
| 02/15/2001 | WO2001010401A1 Stable hydrogenated lupulone antibacterial oral compositions |
| 02/15/2001 | WO2000066584B1 1-AMINO TRIAZOLO¢4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV |
| 02/15/2001 | CA2378587A1 Stable hydrogenated lupulone antibacterial oral compositions |
| 02/14/2001 | EP1075483A2 Hygromycin a derivatives |
| 02/14/2001 | EP1075274A2 Immunomodulators for vaccines |
| 02/14/2001 | EP1075260A2 Novel fatty acid analogues for the treatment of primary and secondary restenosis |
| 02/14/2001 | EP1075259A1 Novel fatty analogues for the treatment of diabetes |
| 02/14/2001 | EP1075258A1 Novel fatty analogues for the treatment of obesity, hypertension and fatty liver |
| 02/14/2001 | CN1283451A Local compsn, contg, tocopherol |
| 02/13/2001 | US6187789 Muscle relaxants for emergency intubation and surgery |
| 02/13/2001 | US6187300 Antiperspirant cream compositions having improved wash-off and antiperspirant efficacy |
| 02/13/2001 | CA2021501C Topical pharmaceutical compositions |
| 02/08/2001 | WO2001008652A1 Skin care composition |
| 02/08/2001 | WO2001008651A1 Skin care composition |
| 02/08/2001 | WO2000061161A3 A pharmaceutical formulation useful for the treatment of hepatitis b, hepatitis c and other viral infections of the liver and a process for its preparation |
| 02/08/2001 | DE10037121A1 Antipyretic composition for treating intensively reared animals, comprising stable, concentrated paracetamol solution in polyethylene glycol and/or polypropylene glycol, added to drinking water or sprayed on feed |
| 02/07/2001 | EP1074266A2 Live attenuated bacteria for use in a vaccine |
| 02/07/2001 | EP1074244A2 Topical composition comprising a tocopherol compound |
| 02/07/2001 | EP1073658A1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
| 02/07/2001 | EP1073653A1 Novel 2-heterocyclically substituted dihydropyrimidines |
| 02/07/2001 | EP1073637A1 3-(amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of hiv related diseases |
| 02/07/2001 | EP1073475A2 Improvements in or relating to diagnostic/therapeutic agents |
| 02/07/2001 | EP1073473A1 Improvements in or relating to contrast agents |
| 02/07/2001 | EP1073445A1 Substance mixture for topical application comprising olive oil and honey |
| 02/07/2001 | EP1073417A1 Pharmaceutical aerosol formulation |
| 02/07/2001 | EP1073408A1 Desensitizing dentifrice containing potassium and tin salts |
| 02/07/2001 | CN1283185A New crystalline polymorphic form of 1-methyl-5-p-toluoylpyrroel-2-acetamidoacetic acid guaiacyl ester (MED 15) |
| 02/07/2001 | CN1283115A Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine |
| 02/07/2001 | CN1283102A Non-whitening underarm compositions |
| 02/07/2001 | CN1061648C Antiarrhythmic and cardioprotective substituted indenoyiguanidines |
| 02/06/2001 | US6184255 Enhanced absorption |
| 02/06/2001 | US6183986 OspA DNA and lyme disease vaccine |
| 02/06/2001 | US6183782 Inhalation composition containing lactose pellets |
| 02/06/2001 | CA2314849A1 Topical composition comprising a tocopherol compound |
| 02/06/2001 | CA2119654C Particles for nmr imaging and method of manufacture |
| 02/01/2001 | WO2001007063A1 Process for the extraction of valerian root |
| 02/01/2001 | WO2001007053A1 Tixocortol pivalate suspension, mouth-wash based thereon and packaging containing same |
| 02/01/2001 | WO2001007047A2 Control of crustacean infestation of aquatic animals |
| 02/01/2001 | WO2000056359A3 Vaccine against streptococcus pneumoniae |
| 02/01/2001 | CA2379395A1 Process for the extraction of valerian root |
| 02/01/2001 | CA2378409A1 Control of crustacean infestation of aquatic animals |
| 01/31/2001 | EP1071433A2 Pharmaceutical composition |
| 01/31/2001 | EP1071427A1 Intermittent claudication therapeutic drugs comprising pyrroloazepines |
| 01/31/2001 | EP1071418A2 New treatments for nervous disorders |
| 01/31/2001 | EP0768884B1 Drugs containing a synergistic mixture of metronidazole and clindamycin |
| 01/31/2001 | CN1282316A Substituted cyslopentane and cyclopentene compounds useful as neuraminidase inhibitors |
| 01/31/2001 | CN1281694A Composite for oxidation-dyeing keratin fibre and its dyeing method |
| 01/30/2001 | US6180370 Preparing preferential antibodies; generating nucleotide sequences coding preferential antibodies, expressing nucleotide sequences in transformed cell and recovering preferential antibodies |
| 01/30/2001 | US6180121 Fragrance enhancing compositions for cosmetic products |
| 01/30/2001 | US6180106 For treating hypersensitivity reaction in mammals; as antitussive agent, antiallergen, antihistmine, to suppress itching and as antiinflammatory agent |
| 01/30/2001 | US6180089 Eliminates or reduces discomfort and pain associated with dentinal hypersensitivity |
| 01/25/2001 | WO2001005356A2 Weight control product comprising a synergistic mixture of guggul extract, phosphate salt and metabolic stimulant |
| 01/25/2001 | WO2001005353A2 USE OF FVIIa OR A TISSUE FACTOR ANTAGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS |
| 01/25/2001 | WO2000061160A3 A pharmaceutical formulation useful for the treatment of hepatitis b hepatitis c and other viral infections of the liver and a pr ocess for its preparation |
| 01/25/2001 | WO2000056360A3 Vaccine against antigens from bacteriae |
| 01/25/2001 | CA2378249A1 Use of fviia or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis |
| 01/24/2001 | EP1070069A1 Bicyclic hydroxamic acid derivatives |
| 01/24/2001 | EP1070065A1 Azabicyclic 5ht1 receptor ligands |
| 01/24/2001 | EP1069900A1 Use of reboxetine for the treatment of neuropsychiatric disorders |
| 01/24/2001 | EP0837669A4 Methods and compositions for use against dental calculus in domestic animals |
| 01/24/2001 | CN1281466A Aggregates of human insulin derivatives |
| 01/24/2001 | CN1281352A Hair colorant preparation |
| 01/24/2001 | CN1061044C Tricyclic 5,6-dihydro-9H-pyrazolo [3,4-C]-1,2,4-triaolo [4,3-alpha] pyridines |
| 01/23/2001 | US6177445 Substituted isoquinolines as ultra short acting neuromuscular blockers |
| 01/23/2001 | US6177093 Method and system for color customizing cosmetic mass products |
| 01/23/2001 | US6177060 Nmr or x-ray lymphography images |
| 01/18/2001 | WO2001003712A1 Composition containing extracts of butyrospermum parkii and the use as medicament or dietary supplement |
| 01/18/2001 | WO2001003693A1 Pharmaceutical composition containing fenofibrate and preparation method |
| 01/18/2001 | WO2001003683A2 Cardioactive composition comprising l-carnitine and its derivatives and crataegus extracts |